Research map: Isobavachin Attenuates Renal and Cardiac Injury in Chronic Hyperuricemia via Modulation of NF‐κB and NLRP3 Signaling Pathways

Back to the article

Papers in this map

  1. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors · Mats Dehlin · 2020 · 1412 citations · Cited by this paper
  2. Mitochondrial Dysfunction in Ulcerative Colitis: Pathogenic Mechanisms and Novel Therapeutics · 2026 · Related
  3. NLRP3 inflammasome in cancer and metabolic diseases · Bhesh Raj Sharma · 2021 · 1128 citations · Cited by this paper
  4. SRM 1650b Administration to Isolated Rat Heart Aggravates Ischemia‐Reperfusion Injury via Mitochondrial Dysfunction and Downregulation of PI3K/Akt Signaling Pathways · 2026 · Related
  5. Effects of Allopurinol on the Progression of Chronic Kidney Disease · Sunil V. Badve · 2020 · 487 citations · Cited by this paper
  6. Glucosamine Promotes Autophagy and Attenuates Hepatic Steatosis Via O ‐GlcNAcylation–Mediated Mechanisms · 2026 · Related
  7. Soluble Uric Acid Activates the NLRP3 Inflammasome · Tárcio Teodoro Braga · 2017 · 449 citations · Cited by this paper
  8. NOTCH3 Modulates Inflammation and Fibrosis in HK2 Cells Under Diabetic Conditions Through TLR4/NF‐κB and TGF‐β1/Smad3 Signaling · 2026 · Related
  9. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism · Xingyong Wan · 2015 · 377 citations · Cited by this paper
  10. MiR‐138‐5p Suppresses Glucose Metabolism to Inhibit the Progression of Nasopharyngeal Carcinoma by Targeting the CENPN/PI3K/Akt/mTOR Signaling · 2026 · Related
  11. The cardio-renal-metabolic connection: a review of the evidence · Marella Marassi · 2023 · 371 citations · Cited by this paper
  12. Nano‐Rosmarinic Acid Protects Against Chlorfenapyr‐Induced Testicular Toxicity Through Modulation of NRF2/HO‐1 and NF‐κB/NLRP3 Signaling Pathways · 2026 · Related
  13. Asymptomatic hyperuricaemia: a silent activator of the innate immune system · Leo A. B. Joosten · 2019 · 328 citations · Cited by this paper
  14. Zingerone Alleviates Acetaminophen‐Induced Liver Damage by Regulating Oxidative Stress, Inflammation, Apoptosis, Endoplasmic Reticulum Stress, and Autophagy · 2026 · Related
  15. Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia · Georgiana Cabău · 2019 · 265 citations · Cited by this paper
  16. SGLT2 Inhibition Attenuates Hippocampal Injury and Cognitive Impairment in Adult‐Onset Hypothyroidism · 2026 · Related
  17. Safety and tolerability of available urate-lowering drugs: a critical review · L. M. Strilchuk · 2019 · 236 citations · Cited by this paper
  18. Silymarin Modulates 3‐Nitropropionic Acid‐Induced Oxidative Neurotoxicity and Apoptosis Through the Inhibition of TRPV1 Channel in Mouse Brain and Hippocampal Neurons · 2026 · Related
  19. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease · Claudio E. Ponticelli · 2020 · 197 citations · Cited by this paper
  20. Industrial Hydrocarbons Exposure Deteriorates Sperm Integrity and Reproductive Function · 2026 · Related
  21. Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990–2017: A Systematic Analysis of the Global Burden of Disease Study 2017 · Saeid Safiri · 2020 · 195 citations · Cited by this paper
  22. Uric Acid and Chronic Kidney Disease: Still More to Do · Richard J. Johnson · 2022 · 158 citations · Cited by this paper
  23. Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation · Yoshitaka Kimura · 2020 · 157 citations · Cited by this paper
  24. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care · Hyon K. Choi · 2021 · 126 citations · Cited by this paper
  25. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway · Yongmei Li · 2021 · 106 citations · Cited by this paper
  26. Metabolism-Associated Molecular Patterns (MAMPs) · Xu Wang · 2020 · 98 citations · Cited by this paper
  27. Hyperuricemia and its related histopathological features on renal biopsy · Shulei Fan · 2019 · 86 citations · Cited by this paper
  28. Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome · Xinghong Zhou · 2024 · 86 citations · Cited by this paper
  29. Gout · Ted R. Mikuls · 2022 · 77 citations · Cited by this paper
  30. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes · Sascha Pilemann-Lyberg · 2019 · 75 citations · Cited by this paper
  31. Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy · Tao Han Lee · 2021 · 72 citations · Cited by this paper
  32. Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease · Waleed Hassan · 2022 · 65 citations · Cited by this paper
  33. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets · Pitchai Balakumar · 2020 · 64 citations · Cited by this paper
  34. Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS/NLRP3 pathway · Bin He · 2023 · 54 citations · Cited by this paper
  35. Soluble uric acid induces myocardial damage through activating the NLRP3 inflammasome · Hailong Zhang · 2020 · 52 citations · Cited by this paper
  36. The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury · Leticia Cuarental · 2022 · 47 citations · Cited by this paper
  37. Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation · Qiulan Lv · 2020 · 46 citations · Cited by this paper
  38. ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome · Xiaoyan Wu · 2021 · 30 citations · Cited by this paper
  39. Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity · Zean Zhao · 2023 · 30 citations · Cited by this paper

Source: OpenAlex (CC0)